Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Octreotide |
EINECS | 616-695-4 |
CAS No. | 79517-01-4 | Density | 1.395 g/cm3 |
PSA | 382.82000 | LogP | 3.02100 |
Solubility | soluble in water | Melting Point |
153-156oC |
Formula | C49H66N10O10S2 | Boiling Point | 1447.228 °C at 760 mmHg |
Molecular Weight | 1079.31 | Flash Point | 829.053 °C |
Transport Information | N/A | Appearance | Colourless to off-white lyophilised solid |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
L-Cysteinamide,D-phenylalanyl-L-cysteinyl-Lphenylalanyl- D-tryptophyl-L-lysyl-Lthreonyl- N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl) propyl]-,cyclic (2f7)-disulfide,acetate (salt);Sandostatin (TN);Octreotide acetate (JAN);Sandostatin LAR;acetic acid; 10-(4-aminobutyl)-19-[(2-amino-3-phenyl-propanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide;Sandostatin;SMS 201-995; |
Article Data | 2 |
Product Name: Sandostatin (CAS NO.79517-01-4)
IUPAC Name: Acetic acid;7-(4-aminobutyl)-16-[(2-amino-3-phenylpropanoyl)amino]-13-benzyl-N-(1,3-dihydroxybutan-2-yl)-4-(1-hydroxyethyl)-10-(1H-indol-3-ylmethyl)-3,6,9,12,15-pentaoxo-18,19-dithia-2,5,8,11,14-pentazacycloicosane-1-carboxamide
Molecular Formula: C49H66N10O10S2
Molecular Weight: 1019.24g/mol
Mol File: 79517-01-4.mol
Boiling point: 1447.228 °C at 760 mmHg
Storage Temperature: -20°C
Flash Point: 829.053 °C
Density: 1.395 g/cm3
Water Solubility: soluble
Index of Refraction: 1.673
Molar Refractivity: 273.948 cm3
Molar Volume: 730.708 cm3
Surface Tension: 79.098 dyne/cm
Enthalpy of Vaporization: 231.842 kJ/mol
Properties: colourless to off-white lyophilised solid
Sandostatin , its CAS NO. is 79517-01-4, the synonyms of Sandostatin(79517-01-4) are D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2-7)-disulfide acetate (salt) ; -Phenylalanyl-L-hemicystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-hemicystyl-L-threoninol cyclic (2-7)-disulfide acetate (salt) ; L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2-7)-disulfide, (R-(R*,R*))-, acetate (salt) ; Octreotide Acetate Depot ; Octreotide acetate ; Octreotide . Its product categories are Amino Acid Derivatives ; Intermediates and Fine Chemicals ; Peptides ; Pharmaceuticals ; Somatostatin receptor .
Sandostatin(79517-01-4) is used as Octapeptide analog of Somatostatin and gastric antisecretory agent. And it is used in treatment of acromegaly.
1. | scu-man TDLo:2587 µg/kg:GIT,LVR | LANCAO Lancet. 348 (1996),1668. | ||
2. | scu-man TDLo:1429 µg/kg:GIT,LVR | LANCAO Lancet. 348 (1996),1668. | ||
3. | scu-rat LD:>50 mg/kg | KSRNAM Kiso to Rinsho. Clinical Report. 21 (1987),5151. | ||
4. | ivn-rat LD50:18,100 µg/kg | IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. 22 (1991),967. | ||
5. | scu-mus LD:>100 mg/kg | KSRNAM Kiso to Rinsho. Clinical Report. 21 (1987),5151. | ||
6. | ivn-mus LD50:72300 µg/kg | IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. 22 (1991),967. |
A poison by subcutaneous and intravenous routes. Human systemic effects: changes in structure or function of endocrine pancreas, liver function tests impaired. When heated to decomposition it emits toxic vapors of NOx and SOx.
WGK Germany: 3